OMC vs TELO · rev $17.27B vs $86.0M cap
Omnicom Group Inc (OMC) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
TELO does not have a complete income-statement cache yet.
OMC currently screens at market cap $21.75B. TELO currently screens at market cap $86.0M.
Not investment advice. Open the OMC and TELO stock pages for the full models.
Not investment advice.